Multicenter Registry for Patients With Childhood.Onset Craniopharyngioma, Xanthogranuloma, Cysts of Rathke's Pouch, Meningioma, Pituitary Adenoma, Arachnoid Cysts
Launched by KLINIKUM OLDENBURG GGMBH · Nov 6, 2019
Trial Information
Current as of July 26, 2025
Recruiting
Keywords
ClinConnect Summary
The KRANIOPHARYNGEOM Registry 2019 is a clinical study that aims to gather important information about patients who have been diagnosed with craniopharyngioma, a type of brain tumor that starts in childhood. This registry will also include patients with other related conditions like xanthogranuloma, meningioma, and various types of cysts in the brain. The goal is to understand how these conditions are diagnosed, treated, and monitored over time. The study is currently looking for participants, and it welcomes individuals from as young as 1 year old up to 18 years old who have recently been diagnosed with craniopharyngioma.
To join the study, patients must have been diagnosed with craniopharyngioma for the first time and be 18 years of age or younger. Parents or guardians will need to give their permission, along with the patient's agreement. Participants can expect to provide information about their health and treatment, which will help doctors learn more about these conditions and improve care for future patients. This registry is a valuable opportunity for families to contribute to research that could lead to better understanding and management of these brain-related issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Diagnosed with craniopharyngioma for the first time
- • 2. Age at diagnosis 18 years or less of age
- • 3. Agreement from patient's parents or legal guardian as well as the patient
- Exclusion Criteria:
- • 1. Age at diagnosis over 18 years of age
- • 2. Diagnosis different from craniopharyngioma
About Klinikum Oldenburg Ggmbh
Klinikum Oldenburg gGmbH is a leading healthcare institution based in Oldenburg, Germany, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent teaching hospital, it combines comprehensive clinical services with a strong emphasis on scientific research, facilitating a collaborative environment for healthcare professionals and researchers. The institution is committed to conducting high-quality clinical studies that adhere to rigorous ethical standards, ultimately contributing to the development of new therapies and treatment modalities across various medical fields. With a focus on patient safety and wellbeing, Klinikum Oldenburg gGmbH plays a vital role in shaping the future of healthcare through its robust clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oldenburg, Niedersachsen, Germany
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials